MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Neuroprotective properties of arylpiperazine-sulphonamides in an in vitro model of Parkinson’s disease

    A. Kingslake, V. Soskic, M. Iravani (Hatfield, United Kingdom)

  • Neuropsychiatric Symptoms in Early-Onset Parkinson’s Disease

    C. Piat, E. Camerucci, A. Mullan, K. Ghoniem, J. Jacobson, G. Patanè, P. Turcano, R. Savica (Rochester, USA)

  • Neuropsychological and quality of life outcome comparison after awake and asleep pallidal deep brain stimulation (DBS) surgery for Parkinson’s disease

    A. Tröster, A. Novak, S. Russell, K. Hanson (Phoenix, USA)

  • Neuropsychological Outcomes After Bilateral Focused Ultrasound Thalamotomy within Essential Tremor

    M. Obolsky, N. Amitrano, N. Patel, S. Sani, M. Afshari, M. Wodziak, B. Bernard, S. Anderson, D. Gonzalez (Chicago, USA)

  • Neurotological evaluation on cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (canvas)

    B. Leao, M. Severiano, G. Santos, H. Teive, M. José, B. Cavalcante-Leao, C. Araújo (Curitiba, Brazil)

  • New DBS targets for dystonia in thalamus and brainstem

    T. Sanger, J. Maclean, J. Olaya, M. Liker (Orange, USA)

  • New machine learning approaches in tic detection: Seeking to learn more about the characteristic of tics

    L. Becker, R. Schappert, N. Brügge, G. Sallandt, F. Li, J. Friedrich, T. Bäumer, C. Frings, C. Beste, R. Stenger, V. Roessner, H. Handels, S. Fudickar, A. Münchau (Lübeck, Germany)

  • New wearable technology for quantification of freezing of gait in school going adolescent with pediatric movement disorders

    V. Sharma, M. Gautam (Agra, India)

  • Next-generation sequencing analysis of circulating microRNAs in multiple system atrophy

    MC. Kuo, SP. Lin, RM. Wu (Taipei, Taiwan)

  • NLX-112 has favorable safety and tolerability and displays efficacy against levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD)

    P. Svenningsson, P. Odin, F. Berquist, K. Wirdefeldt, D. Nyholm, M. Andréasson, I. Markaki, A. Johansson, M. Jergil, C. Jankosky, M. Varney, F. Herbrecht, S. Johnson, A. Newman-Tancredi (Solna, Sweden)

  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley